Evidence map›Paper›PMID 25735269›Full record

ArticleMedical physics2015

Point/counterpoint. Radiotherapy is an appropriate treatment to consider for patients infected with the Ebola virus.

Wilfred F Ngwa, Roland Teboh, Colin G Orton

Abstract read
In one paragraph

Article in Medical physics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Alternative therapies for Covid-19.Materials today. Proceedings · 2022
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wilfred F NgwaDepartment of Radiation Oncology, Harvard Medical School, Boston, Massachusetts 02115 (Tel: 617-525-7131; E-mail: wngwa@lroc.harvard.edu).
Roland TebohDepartment of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 (Tel: 410-502-1751; E-mail: troland1@jhmi.edu).
Colin G Orton

Funding

Brachytherapy in situ dose-painting administered via gold-nanoparticle elutersK01CA172478 · NCI · DANA-FARBER CANCER INST · PI NGWA, WILFRED · 2013 to 2017
$883k
NCI NIH HHS K01 CA172478
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EbolavirusHemorrhagic Fever, EbolaHumansSafetyTime FactorsWhole-Body Irradiation

Identifiers

PMID25735269
PMCPMC5148149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.